glp-1 trump deal Eli Lilly and Novo Nordisk are lowering drug costs thanks to a new with President Trump. 💉 Eli Lilly, Novo Nordisk Strike

Equity concerns with trendy new drugs As the demand for GLP-1 drugs grows and some online companies make it easy for off-label use of the medications, some doctors are concerned about patients having equitable access to the meds

If research design includes injection routes: Clean vial stopper with alcohol swab

Medically reviewed by Oghenefejiro Okifo | MD , Harvard Medical School | Henry Ford Hospital - Detroit, MI on May 24th, 2026

Another NMDA receptor N2B subunit antagonist, EVT 101 [92], was investigated in one phase 2 RCT (NCT01128452) that was terminated early due to a clinical hold issued by the FDA, with no results reported

In women where that medication doesn't work, additional L-Carnitine may help

A new alternative method for testing skin irritation using a human skin model: A pilot study